Actavis Pursuing Generic of UCB’s Neupro

Drug Industry Daily
A A
Actavis has launched a generic challenge against UCB’s Parkinson’s disease drug Neupro, and is facing a patent infringement lawsuit as a result.

To View This Article:

Login

Subscribe To Drug Industry Daily